Expression of CXCL14 and its anticancer role in breast cancer.
about
Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma.Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion.Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients.The role of chemokines in breast cancer pathology and its possible use as therapeutic targetsDifferential Expression of ADAM23, CDKN2A (P16), MMP14 and VIM Associated with Giant Cell Tumor of Bone.Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.Exploring the intrinsic differences among breast tumor subtypes defined using immunohistochemistry markers based on the decision tree.Comparison of gene expression profiles and related pathways in chronic thromboembolic pulmonary hypertension.Epigenetic and genetic deregulation in cancer target distinct signaling pathway domains.The Expression of HSPD1, SCUBE3, CXCL14 and Its Relations with the Prognosis in Osteosarcoma.Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo.Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer.Association of rs1801157 single nucleotide polymorphism of CXCL12 gene in breast cancer in Pakistan and in-silico expression analysis of CXCL12-CXCR4 associated biological regulatory network.CXCL14 and NOS1 expression in specimens from patients with stage I-IIIA nonsmall cell lung cancer after curative resection.Chemokine Network and Overall Survival in Wild-Type and Mutant Ovarian Cancer
P2860
Q33586751-6C3C92E2-E212-4395-A5CE-1A885C770430Q33771084-E934120B-68C3-4922-82A3-4600FAEE60DEQ33917567-8D175189-9F2B-4908-96D1-AF8C3D4B83F1Q34069862-CB76C832-F69E-4803-814C-CE3B7F678CC2Q35739519-D50020EE-46A2-434B-A026-803F6C58B8B4Q37123428-EFDB0B4B-94E2-4786-AE05-B4288D92DC4BQ37370695-E942C766-0CA2-4D6D-8761-D363EBD776EFQ37496096-80CF45E2-0447-4D88-9C32-DD94A2059747Q37649449-52E5021B-271B-49A5-94C9-848AB29FD7E7Q38766777-A5717DA5-849A-4668-83BD-A6B50B44FD3EQ39337489-802CB9A5-232A-4E88-82DD-127B1FA68830Q39350899-3147F54C-3925-4402-9286-F3759898DCAEQ41512848-723D9E7C-3E35-4D3D-84D6-792BA8B13018Q41722916-515522AA-819E-4E3E-A04A-67E944784997Q51735301-073E2161-853C-4C4B-A81B-E081853B0378Q58784692-EF11B549-AB2C-4728-9897-2A69CB9B545B
P2860
Expression of CXCL14 and its anticancer role in breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Expression of CXCL14 and its anticancer role in breast cancer.
@en
Expression of CXCL14 and its anticancer role in breast cancer.
@nl
type
label
Expression of CXCL14 and its anticancer role in breast cancer.
@en
Expression of CXCL14 and its anticancer role in breast cancer.
@nl
prefLabel
Expression of CXCL14 and its anticancer role in breast cancer.
@en
Expression of CXCL14 and its anticancer role in breast cancer.
@nl
P2093
P2860
P1476
Expression of CXCL14 and its anticancer role in breast cancer.
@en
P2093
Feng-Juan Lin
Jian-Min Luo
Xiao-Li Gu
Xiao-Li Yang
Zhen-Zhou Shen
Zhi-Ming Shao
Zhou-Luo Ou
P2860
P2888
P304
P356
10.1007/S10549-012-2206-2
P407
P577
2012-08-22T00:00:00Z